March 23, 2022

Participants 18 years or older needed for Type 2 Diabetes study

Do you have Type 2 Diabetes? Are you 18 years or older? Not currently taking Insulin ? Are you currently being treated with stable doses of daily or weekly GLP-1 receptor agonist, the treatment can be with or without any of the following anti-diabetic drugs with stable doses: Metformin, Sulfonylureasa , Meglitinides (glinides), DPP-4 inhibitors, Sodium-glucose co-transporter 2 inhibitors, Alpha-glucosidase-inhibitors, Thiazolidinediones The University of Alabama at Birmingham, Department of Nutrition Sciences, in collaboration with Novo Nordisk, is conducting a 52 week research study comparing the efficacy and safety of once weekly IcoSema and once weekly semaglutide, Qualified participants will receive study drug free of charge and may be compensated for time and travel. For more information, and to see if you might be eligible to join, please contact (205) 996-4015 or email at